Viewing Study NCT04887857


Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2025-12-25 @ 4:02 PM
Study NCT ID: NCT04887857
Status: COMPLETED
Last Update Posted: 2024-02-12
First Post: 2021-05-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Assess Safety and Tolerability of CC-486 (ONUREGĀ®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)
Sponsor: Celgene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module